EQS-News: Drägerwerk AG & Co. KGaA: Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
EQS-News: Drägerwerk AG & Co. KGaA
/ Key word(s): 9 Month figures/Quarter Results
Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first nine months of 2024 thanks to good overall demand. At around EUR 2,421 million, order intake was around EUR 17 million above the high prior-year figure. Net sales decreased by 0.4 percent (net of currency effects) to EUR 2,295.1 million (9 months 2023: EUR 2,320.9 million) after Dräger had benefited from strong catch-up effects in the prior-year period as a result of the noticeable improvement in delivery capacity and a surge in demand for ventilators in China. Earnings before interest and taxes (EBIT) rose by 4.2 percent to EUR 80.1 million (9 months 2023: EUR 76.9 million). The EBIT margin increased to 3.5 percent (9 months 2023: 3.3 percent). In addition to the operating business performance, several one-off effects with an impact on earnings contributed around EUR 32 million to EBIT. “Our order intake increased in the first nine months of 2024 thanks to good demand for our ‘Technology for Life’ – and was thus able to exceed the high level of the prior year,” says Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG. “Net sales saw robust development and almost reached the high prior-year level despite the challenging comparative figures. Our earnings increased. This was due not only to the operating business but also to measures to improve profitability which included the sale of a non-core local business activity in the Netherlands.” Rising demand for safety technology In the safety division, order intake rose by 6.5 percent (net of currency effects) to EUR 1,052.1 million (9 months 2023: EUR 992.7 million). Almost all product areas recorded higher demand. Growth was driven in particular by our occupational health and safety equipment as well as respiratory and personal protection products. In the medical division, order intake fell by 2.1 percent (net of currency effects) to EUR 1,368.5 million (9 months 2023: EUR 1,410.7 million). This is due in particular to the significantly lower demand for ventilators, which had been supported by an extraordinary surge in demand from China in the same period of the prior year. The significant increase in order volumes in thermoregulation in particular had a positive effect. Safety division continues to grow - base effects weigh on medical division In the medical division, net sales fell by 4.6 percent (net of currency effects) to EUR 1,285.3 million (9 months 2023: EUR 1,359.2 million). This was due in particular to the significant decline in net sales in the Asia-Pacific region, which, as expected, is primarily attributable to the China effect described above. In the same period of the prior year, the segment also benefited from catch-up effects as a result of the noticeable improvement in delivery capacity. One-off effects drive earnings growth The gross margin rose to 44.4 percent (9 months 2023: 44.0 percent) as a result of the increased share of net sales and the improved gross margin of the safety division. Our functional costs increased by 0.4 percent (net of currency effects). Earnings after taxes amounted to EUR 49.4 million (9 months 2023: EUR 47.1 million). Business development in the third quarter Dräger’s net sales in the third quarter decreased by 0.7 percent (net of currency effects) to EUR 774.6 million (Q3 2023: EUR 788.5 million). The gross margin fell to 43.5 percent (Q3 2023: 44.0 percent). EBIT amounted to EUR 24.4 million (Q3 2023: EUR 29.2 million). The EBIT margin came to 3.1 percent (Q3 2023: 3.7 percent). Annual forecast confirmed Further information is available in the financial report at www.draeger.com. Disclaimer
29.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Drägerwerk AG & Co. KGaA |
Moislinger Allee 53-55 | |
23558 Lübeck | |
Germany | |
Phone: | +49 (0)451 882-0 |
Fax: | +49 (0)451 882-2080 |
E-mail: | info@draeger.com |
Internet: | www.draeger.com |
ISIN: | DE0005550602, DE0005550636 (Vorzugsaktien) |
WKN: | 555060, 555063 (Vorzugsaktien) |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange |
EQS News ID: | 2017535 |
End of News | EQS News Service |
|
2017535 29.10.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
The most important financial data at a glance | ||||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
Sales1 | 2.595,01 | 2.780,82 | 3.406,78 | 3.328,42 | 3.045,23 | 3.375,50 | 3.425,00 | |
EBITDA1,2 | 147,91 | 193,71 | 521,07 | 421,00 | 55,80 | 315,00 | 304,00 | |
EBITDA-Margin3 | 5,70 | 6,97 | 15,30 | 12,65 | 1,83 | 9,33 | 8,88 | |
EBIT1,4 | 62,65 | 66,58 | 396,60 | 271,68 | -88,61 | 166,43 | 171,00 | |
EBIT-Margin5 | 2,41 | 2,39 | 11,64 | 8,16 | -2,91 | 4,93 | 4,99 | |
Net Profit (Loss)1 | 34,90 | 33,79 | 249,89 | 154,27 | -63,64 | 111,99 | 104,00 | |
Net-Margin6 | 1,35 | 1,22 | 7,34 | 4,64 | -2,09 | 3,32 | 3,04 | |
Cashflow1,7 | 4,09 | 164,42 | 459,98 | 384,89 | -144,23 | 189,68 | 0,00 | |
Earnings per share8 | 1,42 | 1,38 | 10,19 | 7,13 | -3,41 | 5,86 | 5,40 | |
Dividend per share8 | 0,13 | 0,13 | 0,13 | 0,13 | 0,13 | 1,74 | 1,54 |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: -
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
INVESTOR-INFORMATION | ||||||
©boersengefluester.de | ||||||
Drägerwerk ST | ||||||
WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
555060 | DE0005550602 | AG & Co. KGaA | 806,96 Mio € | 21.06.2010 | Kaufen | 9F5GVM4C+V2 |
PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
7,20 | 17,03 | 0,42 | 11,08 | 0,56 | 4,03 | 0,24 |
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
0,13 | 1,74 | 1,54 | 3,78% |
Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
09.05.2025 | 30.04.2025 | 25.07.2024 | 29.10.2024 | 03.04.2025 |
Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
-3,73% | -7,52% | -8,95% | -7,92% | +0,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.